Therapeutic use of ganglioside GM1 in the treatment of spinal cord injury
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 16, 2003
Grant Date -
Aug 14, 2003
app pub date -
Apr 18, 2002
filing date -
Dec 23, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to a method for amelioration of neurological outcome in humans with spinal cord damage by administration of ganglioside GM.sub.1. Another object of the present invention is to provide combination therapies for the treatment of spinal cord damage comprised of the administration of the ganglioside GM.sub.1 and other drugs which have therapeutical benefit in patients with spinal cord damage, preferably methylprednisolone.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully